American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 6-9 , July 2009

Overcoming Challenges to Influenza Vaccination in Patients With CKD

References 

  1. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333–1340
  2. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186
  3. Mullooly JP, Bridges CB, Thompson WW, et al. Influenza and RSV-associated hospitalizations among adults. Vaccine. 2007;25:846–855
  4. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Norbid Mortal Wkly Rep. 2008;57(RR07):1–60
  5. Centers for Disease Control and Prevention. Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease. http://www.cdc.gov/vaccines/pubs/downloads/b_dialysis_guide.pdfAccessed March 4, 2009
  6. Center for Medicare and Medicaid Services. End stage renal disease program interpretative guidance: version 1.1. http://www.cms.hhs.gov/SurveyCertificationGenInfo/downloads/SCletter09-01.pdfAccessed March 4, 2009
  7. Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis. 2002;35:370–377
  8. Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: The PRISMA Study. Arch Intern Med. 2005;165:274–280
  9. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int. 2003;63:738–743
  10. Scharpé J, Peetermans WE, Vanwalleghem , et al. Immunity of a standard trivalent vaccine in patients on long-term hemodialysis: An open-label trial. Am J Kidney Dis. 2009;54:77–85
  11. Vogtlander NPJ, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus ADME. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine. 2004;22:2199–2201
  12. Herrera GA, Iwane MK, Cortese M, et al. Influenza vaccine effectiveness among 50-64 year old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine. 2007;25:154–160
  13. Birdwell KA, Ikizler MR, Sannella EC, et al. Decreased antibody response to influenza vaccination in kidney transplant recipients: A prospective cohort study. Am J Kidney Dis. 2009;54:112–121
  14. Fox JP, Hall CE, Cooney MK, Foy HM. Influenzavirus infections in Seattle families, 1975-1979.II (Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness). Am J Epidemiol. 1982;116:228–242
  15. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children—Diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003–1032
  16. US Department of Health and Human Services. Healthy People 2010, vol 1 (ed 2). http://www.healthypeople.gov/Document/pdf/Volume1/04CKD.pdfAccessed March 4, 2009
  17. US Renal Data System. 2008 Annual Data Report: Clinical Indicators and Preventive Health. http://www.usrds.org/2008/pdf/V2_05_2008.pdfAccessed March 4, 2009
  18. Bond TC, Patel PR, Krisher J, et al. Association of standing-order policies with vaccination rates in dialysis clinics: A US-based cross-sectional study. Am J Kidney Dis. 2009;54:86–94
  19. Centers for Disease Control and Prevention. Use of standing orders programs to increase adult vaccination rates: Recommendations of the Advisory Committee on Immunization Practices. MMWR Morbid Mortal Wkly Rep. 2000;49(RR01):15–26
  20. Crouse BJ, Nichol K, Peterson DC, Grimm MB. Hospital-based strategies for improving influenza vaccination rates. J Fam Pract. 1994;38:258–261
  21. Stevenson KB, McMahon JW, Harris J, Hilman JR, Helgerson SD. Increasing pneumococcal vaccination rates among residents of long-term care facilities: Provider-based improvement strategies implemented by peer-review organizations in four western states. Infect Control Hosp Epidemiol. 2000;21:705–710
  22. Centers for Disease Control and Prevention. Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: A report on recommendations of the Task Force on Community Preventive Services. MMWR Morbid Mortal Wkly rep. 2005;54(RR05):1–12
  23. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in healthcare professional: A randomized trial. JAMA. 1999;281:908–913
  24. Carmen WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomized controlled trial. Lancet. 2000;355:93–97
  25. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of healthcare workers in long-term care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1–6
  26. Centers for Disease Control and Prevention. Influenza vaccination of health-care personnel. MMWR Morbid Mortal Wkly Rep. 2006;55(RR02):1–16
  27. Wodi AP, Samy S, Ezeanolue , et al. Influenza vaccine; immunization rates, knowledge, and attitudes of resident physicians in an urban teaching hospital. Infect Control Hosp Epidemiol. 2005;26:867–873

PII: S0272-6386(09)00637-4

doi: 10.1053/j.ajkd.2009.04.007

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 6-9 , July 2009

Article Tools